Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of DSC127 Gel for Diabetic Foot Ulcers
NCT01840085Phase 3Terminated
- Sponsor
- Integra LifeSciences
- Start
- Dec 2015
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aclerastide in diabetic foot ulcer (DFU), sponsored by Integra LifeSciences. Started Dec 2015; status: terminated.
02
Drugs
aclerastide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01840085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01840085.